Nordquist - restorative care

Wolverine Blend
BPC-157  / TB500

A synergistic blend designed to support tissue repair, reduce inflammation, and promote optimal recovery.

LEARN MORE
Nordquist - family wellness

Potential Benefits

  • A synergistic blend of BPC-157 and TB500 designed to support advanced tissue repair, reduce inflammation, and promote optimal recovery.
  • BPC-157, a synthetic peptide derived from body protection compound (BPC), targets accelerated wound healing, improved joint health, and enhanced gut repair.
  • TB500, a potent synthetic analog of thymosin beta-4, increases cell migration, angiogenesis, and collagen deposition, supporting muscle recovery and flexibility.
  • This combination enhances tissue regeneration, reduces recovery time, and promotes anti-inflammatory effects, making it ideal for advanced recovery and performance optimization.
  • Perfect for researchers and advanced users seeking to maximize healing, repair soft tissues, and support optimal physical performance without compromising safety.
Learn More

Request An Appointment

Call or send us an email today!
Our staff will respond as soon as possible to give you the info you need.

Contact
Opt-In

Terms Of Service | Privacy Policy

Nordquist - supportive environments

Molecular Nature and Mechanisms

Nordquist - personalized wellness plans

BPC-157

Is a 15-amino-acid synthetic peptide derived from gastric juice, known as Body Protection Compound-157. It promotes localized angiogenesis, (increased bloodflow or the actual building of new vessels and- arteries- Brings more blood flow to the area) collagen synthesis, and tissue repair, particularly in tendons, ligaments, muscles, and gastrointestinal tissue. Its mechanisms include modulation of VEGF expression, interaction with the nitric oxide pathway (delivery of oxygen), fibroblast(connective tissue such as ligaments and tendons) proliferation via FGF-2, gene expression modulation for growth factors, and potential neurological effects through dopamine and GABA pathways.

Nordquist - evidence-based practices

TB-500

Is a synthetic fragment of thymosin beta-4, a 43-amino-acid protein involved in actin regulation. It aids systemic tissue repair by promoting cell migration, regulating cytoskeletal dynamics, enhancing angiogenesis, and modulating inflammation through NF-κB pathways. TB-500 facilitates repair in cardiac, muscular, and wound-healing contexts and supports recruitment of progenitor cells to injury sites.

Therapeutic Applications

Both peptides promote angiogenesis, tissue repair, and anti-inflammatory effects, but their key difference lies in local versus systemic action: BPC-157 acts near the injection site for targeted healing, while TB-500 circulates to support broader tissue repair

Nordquist - personalized wellness plans

BPC-157 Uses:

  • Tendon, ligament, and soft-tissue injuries, especially localized damage
  • Gastrointestinal repair: ulcers, inflammatory bowel disease models, NSAID-induced gastric damage
  • Post-surgical recovery for tendon or gut-specific procedures
  • Experimental neurological applications in animal models
Nordquist - evidence-based practices

TB-500 Uses:

  • Systemic recovery from multiple injuries or chronic tissue damage
  • Muscle recovery and enhanced satellite cell activation
  • Cardiac repair and wound healing through cell migration support
  • Broader post-surgical tissue regeneration, including multi-site procedures

Clinical Insights & Considerations

Combined Use

Researchers and practitioners sometimes combine BPC-157 and TB-500 due to mechanistic complementarity. BPC-157 supports localized vascularization and structural repair, whereas TB-500 enhances systemic cell migration and tissue remodeling. This combination is often considered in complex, chronic, or multi-tissue injuries

BPC-157: Typically administered at 200–500 mcg daily, either orally or via injection, often split into two doses. Treatment cycles generally last 4–8 weeks.

TB-500: Involves an initial loading phase of 4–6 mg per week for 4–6 weeks, followed by a maintenance phase of ~2 mg per week, usually via subcutaneous injection. These regimens are based on community and preclinical research practices; no FDA or EMA-approved human dosing exists.

Both peptides have generally favorable safety profiles in animal research and informal human use. Mild side effects may include injection-site irritation, temporary lethargy, mild gastrointestinal upset (BPC-157), and transient flu-like symptoms.

Caution or contraindications: individuals with active or recent cancer (due to angiogenic activity), pregnant or breastfeeding women, autoimmune conditions, or those under WADA rules for competitive sports should avoid use. No organ toxicity or hormonal disruption has been documented in preclinical studies at standard doses.

Use research-grade peptides verified for purity and correct sequence. Store lyophilized powder at -20°C; reconstitute with bacteriostatic water, and avoid repeated freeze-thaw cycles Recognize that most combination claims are mechanistically supported but not yet confirmed in clinical studies.

BPC-157

  • 15-amino-acid synthetic peptide derived from gastric compounds
  • Supports angiogenesis (blood flow formation)
  • Promotes collagen synthesis and tissue repair
  • May influence nitric oxide pathways and growth factor signaling
  • Associated with tendon, ligament, muscle, and gastrointestinal support

TB-500

  • Synthetic fragment of thymosin beta-4
  • Supports cell migration and tissue regeneration
  • Helps regulate cytoskeletal structure
  • Promotes angiogenesis and inflammation modulation
  • Associated with muscle, cardiac, and wound healing support

Key Difference

  • BPC-157 primarily supports localized healing
  • TB-500 supports systemic recovery across multiple tissues

Preclinical Evidence: Both peptides exhibit significant tissue repair and regenerative effects in rodent and cell studies for tendons, ligaments, muscles, GI tract, cardiac tissue, and wounds.

Clinical Evidence: Limited; human data remain sparse, largely anecdotal, or from small case series. Larger clinical trials are needed to validate efficacy and safety in humans.

Patient Testimonials

Autoimmune Symptoms
Taking Over Your Life?

See How Cherie Fought Back

From Pain
to Progress:

How PRP Helped Nathaniel Move Again

Summary of Wolverine Blend

BPC-157 and TB-500 offer distinct yet complementary pathways for tissue healing—BPC-157 for localized repair and gut protection, TB-500 for systemic regeneration and cell migration. They are a focus of regenerative medicine research but remain preclinical, and human use lacks formal regulatory approval BPC-157 and TB-500 are two peptides studied extensively in preclinical research for tissue repair; BPC-157 primarily aids local tissue healing and gut protection, while TB-500 supports systemic tissue repair and cell migration, with complementary effects when combined.

Partner with Nordquist Integrated Medicine

If you’re experiencing joint discomfort, chronic conditions, or seeking wellness support, it’s time to explore restorative medicine at Nordquist Integrated Medicine. Call us today at (253) 904-3737 to schedule your consultation and learn how our natural therapies can support your journey toward better health and comfort.

Ready to live a life free from pain?

Book your consultation Today!

Proudly Rated 4.9 Stars by Our Patients

Nordquist - expert healthcare

(300+ Reviews)